Home Where the future becomes reality +++ Biotech report by vfa: Biopharmaceuticals successfully gain market share ++++++ Preclinical efficacy and safety data for ViGeneron’s innovative approach to the treatment of Retinitis Pigmentosa ++++++ MPI of Biochemistry: Nature publication addressing the “dark matter” of proteomics ++++++ Non-nutritive sweeteners may affect the human immune system ++++++ LMU Hospital’s annual reception returned this year with exciting topics and a multimedia “magic show” ++++++ Invitris receives 250,000 EUR to complete spin-out from TUM ++++++ Eisbach starts phase I clinical trial with COVID-19 antiviral ++++++ IZB Connects with Shanghai Zhangjiang Hi-Tech Park ++++++ Specific packaging of DNA affects cell division ++++++ Tubulis Enters Strategic Partnership with BMS ++++++ Insempra launches its first functional component for consumer goods ++++++ ERC Advanced Grant of nearly 2.1 million euros for Prof. Dr. Brenda Schulman ++++++ Vivoryon Therapeutics gives update on clinical development of its lead candidate against Alzheimer’s Disease ++++++ Secarna Pharmaceuticals and SciNeuro Pharmaceuticals form partnership ++++++ adivo expands into new headquarters as first clinical study begins ++++++ Thermosome’s Lead Program THE001 receives regulatory approval for first-in-human trial ++++++ Construction of the “New Hauner” at the Grosshadern Campus has started ++++++ Insempra names new Chief Operating Officer ++++++ Training events for project managers and biological safety officers ++++++ The zebrafish brain as a map ++++++ MorphoSys stops proprietary pre-clinical research programs and further optimizes cost structure ++++++ Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris ++++++ When life begins too early ++++++ US-based Neuron23 starts Phase 1 clinical trial in Parkinson’s Disease ++++++ Expansion of the Munich “science line” has started ++++++ Enno Spillner to join Formycon as CFO +++ Biotech report by vfa: Biopharmaceuticals successfully gain market share Preclinical efficacy and safety data for ViGeneron’s innovative approach to the treatment of Retinitis Pigmentosa Max Planck Institute of Biochemistry: Nature publication addressing the “dark matter” of proteomics Non-nutritive sweeteners may affect the human immune system Registration for the IZB Newsletter IZB at the media Facts & Figures about the IZB Laboratories and offices of the IZBThe ideal location for your Biotech start-up Infrastructure of the IZB The Faculty ClubThe IZB Science Club The conference rooms at the IZBRooms for meetings, seminars and networking The hotel and restaurants at the IZBCampus hotel, restaurant and catering The kindergarten Bio KidsA place for little researchers The network events of the IZBBiotech Press-Lounge, IZBrunch and Life Sciences PitchDay Downloads, videos & picture galleries in the IZB media library IZB in Dialog Brochures of the IZB Videos Images
